Managing money effectively starts with choosing the right bank account. Earlier, opening an account often meant visiting bank branches, completing paperwork, and maintaining a minimum balance.
News in Focus


Tata Technologies shares declined on Monday by 5.6 percent as overall market sentiment remained negative.

The IPL 2026 clash between Rajasthan Royals and Chennai Super Kings in Guwahati presents a finely balanced contest shaped by contrasting dynamics.

LG Electronics India stands at an inflection point, where cyclical pressures in margins are being counterbalanced by structural growth levers such as exports, premiumization, and B2B expansion.

ICICI Prudential AMC emerges as a structurally strong compounding story within India’s rapidly financializing economy.

Ashok Leyland shares were down by nearly 4.5 percent on Friday as selling pressure kept markets negative.
Main Regional Stories

Air France’s La Première represents the pinnacle of commercial aviation luxury, engineered as an ultra-exclusive, highly personalized travel experience.

The impending $1.6 billion sale of the Rajasthan Royals marks a defining moment in the financial evolution of the Indian Premier League, delivering extraordinary returns to early and mid-stage investors.

Waaree Energies shares closed 3 percent lower on Friday as overall sentiment in the markets was bearish. As global markets faced selling, Indian equities traded lower for most of the session.

For most large-scale companies, the active user base is in the tens and hundreds of thousands. When this number of people starts experiencing slow page loads or crashes due to peak traffic, it becomes a massive issue.
New Delhi: Punjab National Bank (PNB) increased its fixed de
In early trading (10:02 am), Advanta India is quoting at Rs 856, up Rs 65.85, or 8.33%. It is swapping with volume of 7,271 shares.
Hyderabad: Cipla Ltd will produce the primary three-in-one cocktail anti-AIDS medicine used for children. This accompanies the USFDA clearing a combining quantity of Boehringer Ingelheim’s Viramune, GlaxoSmithKline’s Epivir (or lamivudine) and Bristol-Myers Squibb’s Zerit (or stavudine), which are anti-retrovirals or drugs that fight back AIDS.








